Pregled bibliografske jedinice broj: 1280999
Investigation of the causal relationships between human IgG N-glycosylation and 12 common diseases associated with changes in the IgG N-glycome
Investigation of the causal relationships between human IgG N-glycosylation and 12 common diseases associated with changes in the IgG N-glycome // Human molecular genetics, 31 (2022), 10; 1545-1559 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1280999 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Investigation of the causal relationships between
human IgG N-glycosylation and 12 common diseases
associated with changes in the IgG N-glycome
Autori
Zaytseva, Olga O. ; Sharapov, Sodbo Zh ; Perola, Marcus ; Esko, Tonu ; Landini, Arianna ; Hayward, Caroline ; Wilson, James F. ; Lauc, Gordan ; Aulchenko, Yurii S. ; Klaric, Lucija ; Tsepilov, Yakov A.
Izvornik
Human molecular genetics (0964-6906) 31
(2022), 10;
1545-1559
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
human IgG N-glycosylation ; IgG N-glycome
Sažetak
Changes in the N-glycosylation of immunoglobulin G (IgG) are often observed in pathological states, such as autoimmune, inflammatory, neurodegenerative, cardiovascular diseases and some types of cancer. However, in most cases, it is not clear if the disease onset causes these changes, or if the changes in IgG N-glycosylation are among the risk factors for the diseases. The aim of this study was to investigate the casual relationships between IgG N-glycosylation traits and 12 diseases, in which the alterations of IgG N-glycome were previously reported, using two sample Mendelian randomization (MR) approach. We have performed two sample MR using publicly available summary statistics of genome-wide association studies of IgG N-glycosylation and disease risks. Our results indicate positive causal effect of systemic lupus erythematosus (SLE) on the abundance of N-glycans with bisecting N-acetylglucosamine in the total IgG N-glycome. Therefore, we suggest regarding this IgG glycosylation trait as a biomarker of SLE. We also emphasize the need for more powerful GWAS studies of IgG N-glycosylation to further elucidate the causal effect of IgG N-glycome on the diseases.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
GENOS d.o.o.
Profili:
Gordan Lauc
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE